Loading organizations...
Sage Partners delivers strategic advisory and growth consulting services, focused on accelerating growth and increasing company value. The firm employs a collaborative, hands-on approach, engaging directly with client teams to address strategic organizational challenges. Its services cover venture growth for startups, executive strategic counsel, and commercialization guidance for university intellectual property.
Established in 2001, Sage Partners was founded by experienced professionals recognizing the profound value sustained organizational growth delivers across all stakeholders. Their insight emphasized practical, impactful guidance over theoretical recommendations. The firm designed its client-focused, team-oriented support, leveraging decades of expertise as executives, board members, and entrepreneurs.
Sage Partners assists emerging and established enterprises aiming to invigorate growth. Its vision is to be a dedicated business partner, driving measurable financial and competitive success for clients. The firm focuses on translating innovation into tangible value and adeptly navigating complex growth landscapes.
Key people at Sage Partners.
Sage Partners was founded in 2001 by Ted West (Partner, Co-Founder) and Thomas Doorley, III (Founder, Partner).
Sage Partners was founded in 2001 by Ted West (Partner, Co-Founder) and Thomas Doorley, III (Founder, Partner).
Key people at Sage Partners.
Sage Partners has 4 tracked investments across 4 companies. The latest tracked deal is $61.0M Series B in AnHeart Therapeutics in December 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 14, 2021 | AnHeart Therapeutics | $61.0M Series B | Ting JIA (tj) | Cenova Capital, Innovent Biologics, Laurion Capital Management |
| Oct 1, 2021 | Structure Therapeutics | $100.0M Series B | Mark Nathan Lampert | Qiming Venture Partners, Casdin Capital, Cormorant Asset Management, Eight Roads Ventures, F Prime Capital, Hongshan Capital Group (Sequoia Capital China), Janus Henderson Investors, Lilly Asia Ventures, Monashee Investment Management, Schr"dinger, Stork Capital, Surveyor Capital, Chen YU, Terra Magnum Capital Partners, TF Capital, Woodline Partners, WuXi AppTec |
| Aug 11, 2021 | Visus Therapeutics | $20.0M Other Equity | John DE Koning | Johnson & Johnson Innovation |
| Jul 1, 2020 | Harbour Biomed | $100.0M Series C | JO WEN LIN | OrbiMed, AEF Greater BAY Area Fund, Country Garden Venture Capital, Gtja Investment Group, Octagon Capital |
